Advertisement

Some Aspects of NAP-1 Pathophysiology: Lung Damage Caused by a Blood-Borne Cytokine

  • Antal Rot
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 305)

Abstract

The neutrophil attracting/activating peptide (NAP-1), also called IL-8, was discovered as a result of its chemotactic activity for human neutrophils in vitro (1,2,3). In addition, NAP-1, similarly to other known chemotaxins, has potent neutrophil secretory activity in vitro (1,2,3). NAP-1 is the first described cytokine which attracts neutrophils and the first known chemoattractant acting on neutrophils, but not monocytes. Therefore, on the basis of its behaviour in vitro, one can suggest that NAP-1 and also the recently discovered NAP-2 (4) and NAP-3 (5) (all three belong to the C-X-C cytokine family, exhibit considerable structural homology and have analogous activities in vitro) could be responsible for the induction of the inflammatory cellular infiltrates dominated by neutrophils.

Keywords

Adult Respiratory Distress Syndrome Alveolar Septum Postcapillary Venule Chemotactic Cytokine Lung Damage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Baggiolini, M., A. Walz, and S.L. Kunkel. 1989. Neutrophil activating peptide- 1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84: 1045–1049.PubMedCrossRefGoogle Scholar
  2. 2.
    Matsushima, K. and J.J. Oppenheim. 1989. Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine. 1: 2–13.PubMedCrossRefGoogle Scholar
  3. 3.
    Leonard, E.J. and T. Yoshimura. 1990. Neutrophil attractant/activation protein-1 [NAP-1 (IL-8)]. Am. J. Resp. Cell. Mol. Biol. 2: 479–486.Google Scholar
  4. 4.
    Walz, A., B. Dewald, V. Tscharner and M. Baggiolini. 1989. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III, and platelet factor 4 on human neutrophils. J. Exp. Med. 170: 1745–1750.PubMedCrossRefGoogle Scholar
  5. 5.
    Schröder, J-M., N.L.M. Persoon, and E. Christophers. 1990. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin 8, a second neutrophilactivating protein. J. Exp. Med. 171: 1091–1100.PubMedCrossRefGoogle Scholar
  6. 6.
    Colditz, I.G. 1985. Margination and emigration of leucocytes. Surv. Synth. Path. Res. 4: 44–68.Google Scholar
  7. 7.
    Foster A., D.M. Aked, J-M. Schröder, and E. Christophers. 1989. Acute inflammatory effects of a monocyte-derived Neutrophil-activating peptide in rabbit skin. Immunology. 67: 181–183.PubMedGoogle Scholar
  8. 8.
    Carveth, H.J., J.F. Bohnsack, T.M. Mclntyre, M. Baggiolini, S.M. Prescott, and G.A. Zimmerman. 1989. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem. Biophys. Res. Commun. 162: 387–393.PubMedCrossRefGoogle Scholar
  9. 9.
    Detmers, P.A., S.K. Lo, E. Olsen-Egbert, A. Walz, M. Baggiolini, and Z.A. Cohn. 1990. Neutrophil-activating protein 1-interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J. Exp. Med. 171: 1155–1162.PubMedCrossRefGoogle Scholar
  10. 10.
    Dustin, M.L., R. Rothlein, A.K. Bhan, C.A. Dinarello, and T.A. Springer. 1986. Induction by IL-1 and interferon-gamma: tissue distribution, biochemistry, and function of natural adherence molecule (ICAM-1). J. Immunol. 137: 245–254.PubMedGoogle Scholar
  11. 11.
    Bevilacqua, M.P., S. Stengelin, M.A. Gimbrone, Jr. and B. Seed. 1989. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science. 243: 1160–1165.PubMedCrossRefGoogle Scholar
  12. 12.
    Lindley I., H. Aschauer, J-M. Seifert, C. Lam, W. Brunowsky, E. Kownatzky, M. Thelen, P. Peveri, B. Dewald, V. von Tscharner, A. Walz, M. Baggiolini. 1988. Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: Biological equivalence between natural and recombinant neutrophil activating factor. Proc. Natl. Acad. Sci. USA. 85: 9199–9203.PubMedCrossRefGoogle Scholar
  13. 13.
    Styrt, B. 1989. Species variation in neutrophil biochemistry and function. J. Leukocyte Biol. 46: 63–74.PubMedGoogle Scholar
  14. 14.
    Rot, A. 1990. The role of leukocyte Chemotaxis in inflammation. In: Biochemistry of Inflammation, eds. Evans, S. and J. Whicher, MTP Press, Lancaster. (In press).Google Scholar
  15. 15.
    Rot, A., C. Lam, and I.J.D. Lindley. 1989. Recombinant human NAP-1 shows differing chemotactic and stimulatory activity on cells from different species. Cytokine. 1: 147.Google Scholar
  16. 16.
    Demling, R.H. 1990. Current concepts on the adult respiratory distress syndrome. Circulatory Shock. 30: 297–309.PubMedGoogle Scholar
  17. 17.
    Tracey, K.J., B. Beutler, S.F. Lowry, J. Merryweather, S. Wolpe, I.W. Milsark, R.J. Hariri, T.J. Fahey III, A. Zentella, J.D. Albert, G.T. Shires, and A. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin. Science. 234: 470–474.PubMedCrossRefGoogle Scholar
  18. 18.
    Goldblum, S.E., K. Yoneda, D.A. Cohen, and C.J. McClain. 1988. Provocation of pulmonary vascular endothelial injury in rabbits by human recombinant interleukin-1. Infection and Immunity. 56: 2255–2262.PubMedGoogle Scholar
  19. 19.
    Till, G.O. and P.A. Ward. 1986. Systemic complement activation and acute lung injury. Fed. Proc. 45: 13–18.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Antal Rot
    • 1
  1. 1.Sandoz ForschungsinstitutViennaAustria

Personalised recommendations